Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Aug 16, 2024

BUY
$0.22 - $0.66 $110,983 - $332,950
504,471 New
504,471 $196,000
Q4 2023

Feb 13, 2024

BUY
$0.22 - $0.66 $79,082 - $237,248
359,467 Added 247.9%
504,471 $196,000
Q3 2023

Nov 15, 2023

SELL
$0.2 - $1.78 $11,239 - $100,034
-56,199 Reduced 27.93%
145,004 $31,000
Q2 2023

Aug 14, 2023

BUY
$1.02 - $1.89 $41,291 - $76,510
40,482 Added 25.19%
201,203 $350,000
Q1 2023

May 15, 2023

BUY
$1.0 - $1.35 $65,569 - $88,518
65,569 Added 68.91%
160,721 $175,000
Q4 2022

Feb 14, 2023

BUY
$0.87 - $1.33 $28,369 - $43,369
32,609 Added 52.14%
95,152 $102,000
Q3 2022

Nov 14, 2022

BUY
$1.02 - $1.26 $12,428 - $15,353
12,185 Added 24.2%
62,543 $75,000
Q2 2022

Oct 27, 2022

SELL
$0.91 - $2.01 $1,971 - $4,355
-2,167 Reduced 4.13%
50,358 $52,000
Q2 2022

Aug 15, 2022

SELL
$0.91 - $2.01 $1,971 - $4,355
-2,167 Reduced 4.13%
50,358 $52,000
Q1 2022

Oct 27, 2022

BUY
$1.22 - $2.03 $2,643 - $4,399
2,167 Added 4.3%
52,525 $94,000
Q1 2022

May 13, 2022

BUY
$1.22 - $2.03 $15,036 - $25,019
12,325 Added 30.66%
52,525 $94,000
Q4 2021

Feb 14, 2022

SELL
$1.27 - $2.23 $247,303 - $434,241
-194,727 Reduced 82.89%
40,200 $55,000
Q3 2021

Nov 15, 2021

BUY
$2.12 - $2.76 $498,045 - $648,398
234,927 New
234,927 $509,000

Others Institutions Holding OTLK

About Outlook Therapeutics, Inc.


  • Ticker OTLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,144,992
  • Market Cap $317M
  • Description
  • Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...
More about OTLK
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.